StandardX

Tritium, a key ingredient in the pursuit of fusion energy, does not exist in nature in commercially useful quantities and must be manufactured. We'll create it.

Industrial radioisotopes span manufacturing, security and defence, environmental science, and advanced technology. We'll make more of them.

Medical isotopes are the radioactive materials at the heart of nuclear medicine. We produce more of them.

We’re producing critical isotopes using a novel, high-power accelerator to that is high-yield, versatile and easy to deploy.

Read the latest news and updates from the world's first isotope refinery.

StandardX is building the world's first scalable isotope production platform. Join us.

Our mission is to create the isotopes the world needs to improve cancer care, ensure industrial resilience and meet future energy needs.

StandardX is building the isotope infrastructure the 21st century economy depends on; from medical isotopes to tritium.

London-based deeptech startup StandardX raises £10 million in seed funding led by Vsquared Ventures and East X Ventures. The company plans to use the capital to establish a UK isotope refinery producing rare radioactive materials for cancer care and future fusion energy.

Sep 2026 · Tech Funding NewsNews article

London-based deeptech startup StandardX raises £10 million in seed funding to scale rare-isotope production by building accelerator-based refineries. The facilities could help address critical shortages of rare isotopes used in cancer treatment and in fusion energy development.

Sep 2026 · Europa NowNews article

UK-based deeptech company StandardX raises £10 million in a seed round co-led by Vsquared Ventures and East X Ventures to build a scalable isotope production platform. The round also includes participation from firstminute capital, UKI2S, Brevan Howard Macro Venture, and Geometry.

Sep 2026 · VestbeeNews article

StandardX, a UK-headquartered European deep tech company founded in 2025, raises a £10 million seed round to develop rare isotopes for medicine and fusion energy. Led by Vsquared Ventures and East X Ventures, the funding will support development of what the company calls the world’s first scalable isotope refinery.

Sep 2026 · Business WireNews article